HK1027022A1 - Pellets derived from keratinocytes for use as wound healing substances - Google Patents

Pellets derived from keratinocytes for use as wound healing substances

Info

Publication number
HK1027022A1
HK1027022A1 HK00104312A HK00104312A HK1027022A1 HK 1027022 A1 HK1027022 A1 HK 1027022A1 HK 00104312 A HK00104312 A HK 00104312A HK 00104312 A HK00104312 A HK 00104312A HK 1027022 A1 HK1027022 A1 HK 1027022A1
Authority
HK
Hong Kong
Prior art keywords
keratinocytes
wound healing
healing substances
pellet
pellets derived
Prior art date
Application number
HK00104312A
Other languages
English (en)
Inventor
Hans Van Bossuyt
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of HK1027022A1 publication Critical patent/HK1027022A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00104312A 1991-11-20 2000-07-12 Pellets derived from keratinocytes for use as wound healing substances HK1027022A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91403137 1991-11-20

Publications (1)

Publication Number Publication Date
HK1027022A1 true HK1027022A1 (en) 2001-01-05

Family

ID=8208640

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104312A HK1027022A1 (en) 1991-11-20 2000-07-12 Pellets derived from keratinocytes for use as wound healing substances

Country Status (11)

Country Link
US (2) US6126935A (xx)
EP (2) EP0970701B1 (xx)
JP (1) JP3311351B2 (xx)
AT (2) ATE307599T1 (xx)
CA (1) CA2123683C (xx)
DE (2) DE69231063T2 (xx)
DK (2) DK0970701T3 (xx)
ES (2) ES2252893T3 (xx)
GR (1) GR3034195T3 (xx)
HK (1) HK1027022A1 (xx)
WO (1) WO1993010217A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3377354B2 (ja) * 1995-12-25 2003-02-17 株式会社メニコン 人工皮膚
US5935850A (en) * 1996-09-30 1999-08-10 The Research Foundation Of State University Of New York Model for cell migration and use thereof
US6274163B1 (en) * 1998-04-08 2001-08-14 Keraplast Technologies, Ltd. Keratinous protein material for wound healing applications and method
US6538173B2 (en) * 1998-02-13 2003-03-25 The Wistar Institute Compositions and methods for wound healing
US7846465B1 (en) * 1999-05-28 2010-12-07 Fibrocell Science, Inc. Method of using autologous fibroblasts to promote healing of wounds and fistulas
US6270791B1 (en) 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US6623733B1 (en) * 2001-06-27 2003-09-23 Advanced Cardiovascular Systems, Inc. Methods for treatment of vascular disease and device for preparation of an autologous composition for treating vascular disease
DE10151296A1 (de) * 2001-10-17 2003-04-30 Boehringer Ingelheim Pharma Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
US8394371B2 (en) 2002-02-11 2013-03-12 Neocutis Sa Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
EP2047865A1 (en) 2002-12-03 2009-04-15 Celltran Limited Pharmaceutical compositions of cell lysate and processes for the production and use thereof
GB0304918D0 (en) * 2003-03-05 2003-04-09 Celltran Ltd Cell culture
WO2005071063A1 (en) * 2004-01-27 2005-08-04 The Hospital For Sick Children Methods of making and using skin-derived stem cells
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
GB2444232A (en) * 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
AU2008282931A1 (en) * 2007-07-27 2009-02-05 Immuneregen Biosciences, Inc. Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof
WO2009051622A2 (en) * 2007-10-12 2009-04-23 Immuneregen Biosciences, Inc. Methods for stimulating fibroblast proliferation using substance p analogs
AU2009313656B2 (en) * 2008-11-04 2014-02-20 Stratatech Corporation Dried and irradiated skin equivalents for ready use
US20130230494A1 (en) * 2010-05-25 2013-09-05 The Research Foundation Of State University Of New York Cellular Preparations For Wound Management
JP6216318B2 (ja) * 2011-09-30 2017-10-18 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ 角化細胞に適応したメラニン形成細胞又はその前駆細胞
KR101410065B1 (ko) * 2011-12-09 2014-06-27 테고사이언스 (주) 세포의 유용물질을 상온에서 안정하게 보존하는 방법
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
EP3132809A1 (en) 2015-08-21 2017-02-22 Bioskinco GmbH Composition and products comprising senescent cells for use in tissue regeneration
IL293492A (en) * 2019-12-02 2022-08-01 Avant Meats Company Ltd Methods for producing meat by growing cells in vitro
US11306342B2 (en) 2019-12-02 2022-04-19 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof
US20220333148A1 (en) * 2021-04-09 2022-10-20 Avant Meats Company Limited Cell hydrolysate composition from cultivated cells and applications thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
LU73893A1 (xx) * 1975-11-28 1977-06-09
US4299819A (en) * 1979-01-02 1981-11-10 Sloan-Kettering Institute For Cancer Research Process for treating burn victims
US4254226A (en) * 1979-09-13 1981-03-03 Sloan Kettering Institute For Cancer Research Process for growing human epidermal cells in tissue culture
US4304866A (en) * 1979-11-14 1981-12-08 Massachusetts Institute Of Technology Transplantable sheets of living keratinous tissue
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US5000963A (en) * 1983-06-14 1991-03-19 Hefton John M Method of treating the skin using human epidermal sheets
US4673649A (en) * 1983-07-15 1987-06-16 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
US4940666A (en) * 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
DE3688168T2 (de) * 1985-08-14 1993-10-28 Memorial Hospital Cancer Epidermiszellenextrakte und Verfahren zur Verbesserung der Wundheilung und zur Regenerierung der Epidermis.
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
JPH0687301B2 (ja) * 1986-01-24 1994-11-02 富士写真フイルム株式会社 磁気記録媒体の製造方法
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
US4888291A (en) * 1987-06-19 1989-12-19 President And Fellows Of Harvard College Human epithelium originating from cell cultures
IT1207525B (it) * 1987-06-23 1989-05-25 Ist Naz Ric Sul Cancro Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
JPH01256330A (ja) * 1988-04-04 1989-10-12 Zenkoku Nogyo Kyodo Kumiai Rengokai ハイブリッド稲の種子生産方法
CA2000181A1 (en) * 1988-10-14 1990-04-14 Chung-Faye Chao Process for producing cultured epidermal sheet, product and method of use
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
US5262298A (en) * 1989-05-12 1993-11-16 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production
CA2018228C (en) * 1989-06-05 1996-02-27 Nancy L. Parenteau Cell culture systems and media
US5130142A (en) * 1990-10-31 1992-07-14 The Practer & Gamble Company Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor

Also Published As

Publication number Publication date
US6126935A (en) 2000-10-03
DK0615545T3 (da) 2000-10-30
DE69231063D1 (de) 2000-06-21
EP0970701A3 (en) 2001-12-05
DK0970701T3 (da) 2006-03-06
DE69231063T2 (de) 2001-01-11
EP0615545A1 (en) 1994-09-21
EP0615545B1 (en) 2000-05-17
ATE307599T1 (de) 2005-11-15
EP0970701B1 (en) 2005-10-26
EP0970701A2 (en) 2000-01-12
ES2252893T3 (es) 2006-05-16
DE69233558T2 (de) 2006-07-27
JPH07501214A (ja) 1995-02-09
DE69233558D1 (de) 2005-12-01
WO1993010217A1 (en) 1993-05-27
US5866167A (en) 1999-02-02
ATE193057T1 (de) 2000-06-15
CA2123683A1 (en) 1993-05-27
CA2123683C (en) 2007-10-30
ES2149779T3 (es) 2000-11-16
GR3034195T3 (en) 2000-11-30
JP3311351B2 (ja) 2002-08-05

Similar Documents

Publication Publication Date Title
HK1027022A1 (en) Pellets derived from keratinocytes for use as wound healing substances
AU641488B2 (en) Human hematopoietic stem cell
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
EP0764719A3 (en) Methods for animal cell culture
DK0674715T4 (da) Fremgangsmåde til stabil transformation af hvede
ATE447009T1 (de) Verfahren zur herstellung angereicherter hämatopoietischer zusammensetzungen, dadurch hergestellte zusammensetzungen sowie deren verwendungen
DK0843961T3 (da) Kimærisk mus og fremgangsmåde til at producere samme
DE69637631D1 (de) Künstliche säuger chromosome
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
EP0763057A4 (en) METHOD OF MULTIPLICATION AND DIFFERENTIATION OF B CELLS AND THEIR USE
WO2000056905A3 (en) Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
CO4370126A1 (es) Un acido nucleico aislado, un acido nucleico recombinante, una celula vegetal y un metodo de produccion de ellos . .
EP0249432A3 (en) Transformation and foreign gene expression with plant species
CA2087969A1 (en) Protease resistant pdgf and methods of use
EP0378921A3 (en) Enhancement of plant metabolite production by timed elicitation
AU5391886A (en) Method and device for the in vitro culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants
AU529693B2 (en) Undifferentiated plant cell cultivation
WO1996007730A3 (de) Chemisches verfahren zur förderung der proliferation von tierischen zellen
JPS5774093A (en) Method of increasing interferon production
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
WO1993023529A3 (fr) Culture stabilisee d'agregats cellulaires et procede de developpement des embryons a partir d'une souche proembryogene destine a la regeneration de la vigne
WO1997045547A3 (de) Lokalisierter zelltod in pflanzen
JPS5571491A (en) Preparation of proline acylase
JPS5765184A (en) Stable immobilized adenylate kinase composite and its preparation
JPS54110390A (en) Preparation of rifamycin s

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091119